These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 28467993)

  • 1. Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.
    Tscheppe A; Breiteneder H
    Int Arch Allergy Immunol; 2017; 172(4):187-202. PubMed ID: 28467993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives.
    Linhart B; Valenta R
    Vaccine; 2012 Jun; 30(29):4328-35. PubMed ID: 22100888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant allergens for pollen immunotherapy.
    Wallner M; Pichler U; Ferreira F
    Immunotherapy; 2013 Dec; 5(12):1323-38. PubMed ID: 24283843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant allergens.
    Valenta R; Vrtala S; Laffer S; Spitzauer S; Kraft D
    Allergy; 1998 Jun; 53(6):552-61. PubMed ID: 9689336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant hypoallergens for immunotherapy of Parietaria judaica pollen allergy.
    Asturias JA
    Front Biosci (Landmark Ed); 2009 Jan; 14(12):4606-17. PubMed ID: 19273375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interests of recombinant allergens in the practice of allergy].
    Karoui O; Leimgruber A; Spertini F
    Rev Med Suisse; 2013 Jan; 9(368):22-7. PubMed ID: 23367699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From allergen structure to new forms of allergen-specific immunotherapy.
    Valenta R; Kraft D
    Curr Opin Immunol; 2002 Dec; 14(6):718-27. PubMed ID: 12413521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.
    Ferreira F; Hirtenlehner K; Jilek A; Godnik-Cvar J; Breiteneder H; Grimm R; Hoffmann-Sommergruber K; Scheiner O; Kraft D; Breitenbach M; Rheinberger HJ; Ebner C
    J Exp Med; 1996 Feb; 183(2):599-609. PubMed ID: 8627171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recombinant allergens for diagnosis and specific immunotherapy--value in pediatric patients].
    Couderc R; Just J
    Bull Acad Natl Med; 2013 Mar; 197(3):645-59; discussion 659-60. PubMed ID: 25163347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant allergens for immunotherapy.
    Chapman MD; Smith AM; Vailes LD; Pomés A
    Allergy Asthma Proc; 2002; 23(1):5-8. PubMed ID: 11894735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens.
    Valenta R; Linhart B; Swoboda I; Niederberger V
    Allergy; 2011 Jun; 66(6):775-83. PubMed ID: 21352238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant allergens for diagnosis and therapy of allergic disease.
    Chapman MD; Smith AM; Vailes LD; Arruda LK; Dhanaraj V; Pomés A
    J Allergy Clin Immunol; 2000 Sep; 106(3):409-18. PubMed ID: 10984358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified recombinant allergens for safer immunotherapy.
    Ferreira F; Briza P; Inführ D; Schmidt G; Wallner M; Wopfner N; Thalhamer J; Achatz G
    Inflamm Allergy Drug Targets; 2006 Jan; 5(1):5-14. PubMed ID: 16613559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular approach to allergy diagnosis and therapy.
    Ferreira F; Wolf M; Wallner M
    Yonsei Med J; 2014 Jul; 55(4):839-52. PubMed ID: 24954310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel strategies for the development of a vaccine for Parietaria allergy.
    Bonura A; Colombo P
    Int J Immunopathol Pharmacol; 2011; 24(2):297-304. PubMed ID: 21658304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From allergen genes to new forms of allergy diagnosis and treatment.
    Vrtala S
    Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.